Anti-remodeling potencies of the soluble guanylate cyclase activator BAY 41-2272 in human lung fibroblasts

被引：0
|
作者：
Lambers, Christopher
Roth, Michael
Hofbauer, Elisabeth
Petkov, Venzel
Block, Lutz-Henning
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Pulmonary hypertension; Cell biology; Idiopathic pulmonary fibrosis;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3423
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effect of BAY 41-2272, a Soluble Guanylate Cyclase Agonist, in Human Lymphocytes
    Carvalho, Marina
    Vendramini, Paola
    Soeiro Pereira, Paulo Vtor
    Neto, Antonio Condino
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S53 - S53
  • [2] Effect of Bay 41-2272, a Soluble Guanylate Cyclase Agonist, in Lymphocytes
    Wall Barbosa de Carvalho, Marina Uchoa
    Ferreira Rosa, Paola Vendramini
    Soeiro Pereira, Paulo Vitor
    Antunes, Edson
    Condino Neto, Antonio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S54 - S54
  • [3] Effect of BAY 41-2272, a soluble guanylate cyclase agonist, in lymphocytes
    Uchoa Wall Barbosa de Carvalho, M.
    Vendramini Ferreira Rosa, P.
    Soeiro Pereira, P., V
    Antunes, E.
    Condino Neto, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 137 - 137
  • [4] BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes
    Soeiro-Pereira, P. V.
    Falcai, A.
    Kubo, C. A.
    Oliveira-Junior, E. B.
    Marques, O. C.
    Antunes, E.
    Condino-Neto, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (05) : 1617 - 1630
  • [5] Anti-leukocyte properties of a novel non NO-based soluble guanylate cyclase activator, BAY 41-2272
    Foster, P
    Mathur, A
    McLean, P
    Perretti, M
    Moncada, S
    Ahluwalia, A
    Hobbs, A
    FASEB JOURNAL, 2003, 17 (05): : A1052 - A1052
  • [6] Effects Of Soluble Guanylate Cyclase Activator BAY 41-2272 In Murine Models Of Pulmonary Hypertension And Acute Lung Injury
    Voelker, M. T.
    Hoelman, A.
    Fichtner, F.
    Sack, U.
    Kamprad, M.
    Busch, T.
    Kaisers, U.
    Laudi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [7] Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus
    Deruelle, P
    Grover, TR
    Storme, L
    Abman, SH
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (04) : L727 - L733
  • [8] Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272
    Hobbs, AJ
    Moncada, S
    VASCULAR PHARMACOLOGY, 2003, 40 (03) : 149 - 154
  • [9] BAY 41-2272, a Soluble Guanylate Cyclase Stimulator, Relaxes Isolated Human Ureter in a Standardized In Vitro Model
    Miyaoka, Ricardo
    Mendes, Camila
    Schenka, Andre
    Gonzalez, Paulo Gabriel
    de Nucci, Gilberto
    Antunes, Edson
    Monga, Manoj
    D'Ancona, Carlos Arturo Levi
    Monica, Fabiola Zakia
    UROLOGY, 2014, 83 (01) : 256.e1 - 256.e7
  • [10] Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator
    Priviero, FBM
    Baracat, JS
    Teixeira, CE
    Claudino, MA
    De Nucci, G
    Antunes, E
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (09) : 728 - 734
12345